Page last updated: 2024-12-10

hsr 609

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

HSR 609: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3081352
MeSH IDM0273696

Synonyms (8)

Synonym
188199-97-5
1-piperidinepropanoic acid, 4-(8-fluoro(1)benzoxepino(4,3-b)pyridin-11(5h)-ylidene)-, dihydrate
hsr609
3-(4-(8-fluoro-5,11-dihydrobenz(b)oxepino(4,3-b)pyridin-11-ylidene) piperidino)propionic acid dihydrate
3-(4-(8-fluoro-5,11-dihydrobenz(b)oxepino(4,3-b)pyridin-11-ylidene)piperidin-1-yl)propionic acid dihydrate
fy-609
hsr 609
DTXSID10172166
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]